RAPID: Airborne CoV-2 Viability and Oxidation
- Funded by National Science Foundation (NSF)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$199,997Funder
National Science Foundation (NSF)Principal Investigator
Barbara TurpinResearch Location
United States of AmericaLead Research Institution
University of North Carolina at Chapel HillResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Environmental stability of pathogen
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This RAPID project seeks to improve the understanding of the airborne transmission of (SARS) CoV-2, the virus behind the COVID-19 pandemic, via sub-micron airborne particles. Chamber experiments will be conducted to help determine how long (SARS) CoV-2 remains viable in sub-micron aerosol and how atmospheric oxidation, particle size, and other environmental conditions affect viability. The team includes well-established infectious-disease scientists, coronavirus microbiologists and aerosol scientists with a unique combination of techniques and instruments.
The two objectives of this research are to: (1) Conduct controlled chamber experiments using a non-pathogenic model coronavirus embedded in submicron aerosol in the presence/absence of ozone (O3) and hydroxyl (OH) radicals (separately) to examine how viability is influenced by atmospheric oxidation; and (2) Measure the concentrations of (SARS) CoV-2 and non-pathogenic T3 bacteriophage in aerosol with a novel BioSpot sampler and a gelatin filter sampler in at least 2 locations (e.g., wastewater treatment plant, hospital, daycare, nursing home, grocery store, classroom), and if viable viruses are detected to examine the ability of airborne O3 or OH radical treatment to inactivate the airborne (SARS) CoV-2 virus.
This research is expected to lead to a better understanding of the viability of coronaviruses in sub-micron aerosol. It is anticipated that this effort will provide information relevant to the improved design of mitigation measures and shared indoor/outdoor spaces that are more resilient to respiratory virus transmission and more conducive to protecting public health.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
The two objectives of this research are to: (1) Conduct controlled chamber experiments using a non-pathogenic model coronavirus embedded in submicron aerosol in the presence/absence of ozone (O3) and hydroxyl (OH) radicals (separately) to examine how viability is influenced by atmospheric oxidation; and (2) Measure the concentrations of (SARS) CoV-2 and non-pathogenic T3 bacteriophage in aerosol with a novel BioSpot sampler and a gelatin filter sampler in at least 2 locations (e.g., wastewater treatment plant, hospital, daycare, nursing home, grocery store, classroom), and if viable viruses are detected to examine the ability of airborne O3 or OH radical treatment to inactivate the airborne (SARS) CoV-2 virus.
This research is expected to lead to a better understanding of the viability of coronaviruses in sub-micron aerosol. It is anticipated that this effort will provide information relevant to the improved design of mitigation measures and shared indoor/outdoor spaces that are more resilient to respiratory virus transmission and more conducive to protecting public health.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.